Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromichi Wada

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Internal Medicine (Tokyo, Japan)|April 18, 2014
Matters of controversy regarding lipid therapy for Japanese patients with coronary artery diseaseMaki Komiyama, Hiromichi Wada, Koji Hasegawa
European Cardiology|July 17, 2023
When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early InterventionMoritake Iguchi, Hiromichi Wada, Felipe Martínez, et al.
BMJ Case Reports|February 21, 2014
Massive haemoptysis following dabigatran administration in a patient with bronchiectasisManabu Hayama, Hideki Inoue, Hiromichi Wada, et al.
European Cardiology|June 29, 2026
Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCMKoji Hasegawa, Moritake Iguchi, Hiromichi Wada, et al.
JRSM Cardiovascular Disease|May 29, 2026
Lipid-lowering therapy: Evidence and future perspectiveMaki Komiyama, Hiromichi Wada, Gheorghe-Andrei Dan, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 3, 2016
[Functional Analysis of GATA4 Complex, a Cardiac Hypertrophy-response Transcriptional Factor, Using a Proteomics Approach]Yoichi Sunagawa, Yasufumi Katanasaka, Hiromichi Wada, et al.
Molecular and Cellular Biochemistry|July 23, 2003
Biological role of p300 in cardiac myocytesTetsuhiko Yanazume, Tatsuya Morimoto, Hiromichi Wada, et al.
Diabetes Care|June 27, 2013
Response to Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639Noriko Satoh-Asahara, Akira Shimatsu, Hiromichi Wada, et al.
European Cardiology|July 31, 2024
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?Maki Komiyama, Moritake Iguchi, Hiromichi Wada, et al.
The Journal of Biological Chemistry|December 12, 2001
Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophyTetsuhiko Yanazume, Koji Hasegawa, Hiromichi Wada, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Internal Medicine (Tokyo, Japan)|April 18, 2014
Matters of controversy regarding lipid therapy for Japanese patients with coronary artery diseaseMaki Komiyama, Hiromichi Wada, Koji Hasegawa
European Cardiology|July 17, 2023
When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early InterventionMoritake Iguchi, Hiromichi Wada, Felipe Martínez, et al.
BMJ Case Reports|February 21, 2014
Massive haemoptysis following dabigatran administration in a patient with bronchiectasisManabu Hayama, Hideki Inoue, Hiromichi Wada, et al.
European Cardiology|June 29, 2026
Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCMKoji Hasegawa, Moritake Iguchi, Hiromichi Wada, et al.
JRSM Cardiovascular Disease|May 29, 2026
Lipid-lowering therapy: Evidence and future perspectiveMaki Komiyama, Hiromichi Wada, Gheorghe-Andrei Dan, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 3, 2016
[Functional Analysis of GATA4 Complex, a Cardiac Hypertrophy-response Transcriptional Factor, Using a Proteomics Approach]Yoichi Sunagawa, Yasufumi Katanasaka, Hiromichi Wada, et al.
Molecular and Cellular Biochemistry|July 23, 2003
Biological role of p300 in cardiac myocytesTetsuhiko Yanazume, Tatsuya Morimoto, Hiromichi Wada, et al.
Diabetes Care|June 27, 2013
Response to Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639Noriko Satoh-Asahara, Akira Shimatsu, Hiromichi Wada, et al.
European Cardiology|July 31, 2024
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?Maki Komiyama, Moritake Iguchi, Hiromichi Wada, et al.
The Journal of Biological Chemistry|December 12, 2001
Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophyTetsuhiko Yanazume, Koji Hasegawa, Hiromichi Wada, et al.
Pageof 16